Abstract:The detection of breast cancer from cell-free DNA (cfDNA) offers a new approach with the potential to benefit individual screening and early detection. However, identifying breast cancer from cfDNA remains a major challenge when one uses conventional short-read sequencing. Methylation and DNA fragmentation characteristics provide highly informative biomarkers for detecting and monitoring cancer. To characterize these genomic features from cfDNA, we developed an approach using single molecule Nanopore sequencing. Single cfDNA molecules are sequenced intact with the methylation and fragment size directly extrapolated from Nanopore data. Moreover, our approach requires small amounts of cfDNA to discern specific genomic features from individual molecules. Thus, the use of Nanopore sequencing provides both methylation and fragment size as directly measured from native cfDNA without the use of any chemical processing or other molecular manipulation. We studied an extended breast cancer cohort with in total 1080 of samples, consisting of 440 untreated breast cancer patients and 640 healthy controls. Nanopore sequencing analysis of these cfDNA samples identified a range of 1 to 4 million CpG sites from 1 ml of plasma. Leveraging the cohort, we developed an ensemble classifier for breast cancer detection based on cfDNA methylation and fragmentation. The classifier leveraged a leave-one-out cross-validation (LOOCV) to generate predicted probability. We created nucleosome-specific methylation scores as the input features to the classifier, which scores quantified the similarity of each sample's methylation profile to a training set on a selected set of CpG sites associated with cancers. Furthermore, we also identified DNA fragmentation features, revealing distinct mono-nucleosome and di-nucleosome patterns that distinguish cancers from healthy controls. Aggregating the DNA nucleosome-specific scores and fragmentation features, we built an ensemble LOOCV random forest model. We applied the model to the breast cancer cohort and achieved a detection specificity of 74%, a sensitivity of 71%, and an overall accuracy of approximately 73%. The area under the receiver operating characteristic curve (AUROC) reached 80%. We validated the classifier with two external independent cohorts. Validation cohort 1 demonstrated as a specificity of 85%, a sensitivity of 80%, and overall accuracy of 83% with AUROC of 90%. Validation cohort 2 without controls demonstrated that the classifier achieved a sensitivity of 94%. Both validation sets confirm that our model can achieve excellent performance for early breast cancer detection. In summary, our findings demonstrate that nanopore sequencing provides cfDNA methylation and fragment profiling that enables breast cancer detection. This approach holds the potential to improve cancer diagnosis and treatment outcomes. Citation Format: Xiangqi Bai, Billy T. Lau, Alison Almada, Sue Grimes, Tianqi Chen, Hojoon Lee, Hanlee P. Ji. A nanopore sequencing approach characterizes cell-free DNA methylation-fragmentomics profiles indicative of breast cancer in a large cohort [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 4920.

A deep embedded refined clustering approach for breast cancer distinction based on DNA methylation

A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation

Application of Feature Selection and Deep Learning for Cancer Prediction Using DNA Methylation Markers

Learning Deep Features for Dna Methylation Data Analysis

Deep Neural Network for Analysis of DNA Methylation Data

Abstract 6697: Deep learning algorithm for cancer detection using multimodal characteristics of whole methylome sequencing of cf-DNA

Classification of Large DNA Methylation Datasets for Identifying Cancer Drivers

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

A Nonparametric Bayesian Approach for Clustering Bisulfate-Based DNA Methylation Profiles

XAI-MethylMarker: Explainable AI approach for biomarker discovery for breast cancer subtype classification using methylation data

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

Noninvasive Lung Cancer Early Detection via Deep Methylation Representation Learning.

A Novel Computational Method For Detecting Dna Methylation Sites With Dna Sequence Information And Physicochemical Properties

Convolutional Neural Networks In Classifying Cancer Through DNA Methylation

A machine learning-based method for feature reduction of methylation data for the classification of cancer tissue origin

Abstract 4920: A nanopore sequencing approach characterizes cell-free DNA methylation-fragmentomics profiles indicative of breast cancer in a large cohort

Abstract 3666: Multi-cancer early detection using metrics of DNA methylation based epigenetic instability

An Intelligent Classification System for Cancer Detection Based on DNA Methylation Using ML and Semantic Knowledge in Healthcare

Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects

Application of the Rank-Based Method to DNA Methylation for Cancer Diagnosis.

Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers